Barong, Velmer S.

HRN: 29-39-21  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/30/2026
CO-AMOXICLAV 625MG (TAB)
07/30/2026
08/06/2026
PO
625mg
TID
INFECTED WOUND
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: